 |
Arsenic trioxide |
|---|---|
| Trade Name | Trisenox |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2003-05-13 00:00:00 |
| Sponsor | Teva Branded Pharmaceutical Products R&D;, Inc.;41 Moores Road, P.O. Box 4011;Frazer, Pennsylvania, 19355 |
